Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3961505 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL27907505 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL14977023 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL1389427 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL17841690 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL10413535 | 0.98 | NAAA (0.55) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL6372957 | 0.96 | NAAA (0.53) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL702877 | 0.96 | NAAA (0.52) | NAAAGPR84HCAR2EPHX1TSHR | |
| Phosphonic Acid SCHEMBL15101509 | 0.92 | NAAA (0.49) | NAAAGPR84HCAR2EPHX1TSHR | |
| SCHEMBL942674 | 0.91 | ALDH1A1 (0.48) | NAAAGPR84HCAR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392519-A1 | A LIQUID DISINFECTING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-07-03 | — | — | EP | claimed |
| US-20240197588-A1 | ANTIMICROBIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2024-06-20 | — | — | US | claimed |
| EP-4326066-A2 | ANTIMICROBIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-02-28 | — | — | EP | claimed |
| CN-117580561-A | Hydratable concentrated surfactant compositions containing esters | 联合利华知识产权控股有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-117064786-B | Silk fibroin nanoparticle and preparation method and application thereof | 广东粤港澳大湾区黄埔材料研究院 | 2024-01-02 | — | — | CN | claimed |
| CN-117222313-A | Antimicrobial compositions | 联合利华知识产权控股有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-117064786-A | Silk fibroin nanoparticle and preparation method and application thereof | 广东粤港澳大湾区黄埔材料研究院 | 2023-11-17 | — | — | CN | claimed |
| US-20230301883-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-09-28 | — | — | US | claimed |
| US-20230301886-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2023-09-28 | — | — | US | claimed |
| EP-4216911-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-08-02 | — | — | EP | claimed |
| EP-4216909-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-08-02 | — | — | EP | claimed |
| CN-116322610-A | Moisturizing antibacterial composition | 联合利华知识产权控股有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116157111-A | Moisturizing antimicrobial compositions | 联合利华知识产权控股有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-116035949-A | Oil balance type low-turbidity high-compatibility cosmetic composition | 上海永熙信息科技有限公司 | 2023-05-02 | — | — | CN | claimed |
| WO-2023025575-A1 | A LIQUID DISINFECTING COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-03-02 | — | — | WO | claimed |
| WO-2022063596-A1 | MOISTURIZING ANTIBACTERIAL COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-03-31 | — | — | WO | claimed |
| EP-4392519-A1 | A LIQUID DISINFECTING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392519-A1 | A LIQUID DISINFECTING COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-07-03 | — | — | EP | disclosed |
| US-20050226824-A1 | Sun protecting emulsion provided with a foam dispenser | COGNIS IP MANAGEMENT GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| US-20050152861-A1 | Cosmetic antiperspirant roll-on formulations based on a w/o emulsion | COGNIS IP MANAGEMENT GMBH (DE) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240197588-A1 | ANTIMICROBIAL COMPOSITION | MPO, DNASE1, ELANE | NAAA 675/4885GPR84 3116/4885HCAR2 4715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.